Managing Type 2 Diabetes: Empagliflozin in Focus

This presentation explores empagliflozin, a treatment for type 2 diabetes, focusing on its benefits, addressing patient concerns about side effects like genital candidiasis, and emphasising strategies for therapy continuation despite mild adverse effects. It highlights the importance of regular follow-up assessments at specified intervals to monitor effectiveness and outlines the clinical justifications for sustaining long-term therapy. Finally, the presentation concludes by reinforcing the...